Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO for Ischemia/Reperfusion Injury in Liver Transplant
NCT01172691Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jul 2010
- Primary completion
- Jan 2014
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in ischemia-reperfusion injury (IRI), sponsored by Baylor Scott & White Research Institute. Started Jul 2010; status: completed.
02
Drugs
nitric oxide
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01172691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172691.